Dimension III

Dimension

vc$500MCo-investsLeads rounds

◆ Fund Size

$500M

◆ Check Size

$1.0M→$30.0M

◆ Location

United States

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Investment Thesis

Digitization of drugmaking through convergence of biotechnology and artificial intelligence/computing tools in drug discovery and development.

◆ About Dimension

Dimension is a multistage, research-oriented investment firm partnering with companies across the frontiers of science and compute.

◆ Sectors

BiotechDrug DiscoveryGenerative AIAI InfrastructureAdvanced Materials

◆ Stages

seedseries-aseries-bseries-c

◆ Geography Focus

United States

◆ Team

Name	Title	Role	Links
Adam Goulburn	Investment Team Member	Investment Team Member	in
Bauer LeSavage	PhD, Research Associate	Research Associate	in 𝕏
Dar	Co-founder and Managing Partner	Partner
Frank Gao	PhD, Research Associate	Research Associate	in 𝕏
Nan Li	Investment Team Member	Investment Team Member	in
Nikhil Namburi	Investment Team Member	Investment Team Member	𝕏
Rami Hathwar	Investment Team Member	Investment Team Member	in
Simon Barnett	Partner & Head of Research	Partner	in 𝕏
Zavain Dar	Investment Team Member	Investment Team Member	𝕏

◆ Notable Investments

Chai DiscoveryAspect BiosystemsNewLimitModal LabsEnveda BiosciencesOdyssey TherapeuticsMonte Rosa TherapeuticsRecursion Pharma

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Dimension III invest in?

Dimension III invests in Biotech, Drug Discovery, Generative AI, AI Infrastructure and Advanced Materials at the seed, series-a, series-b and series-c stages.

Which geographies does Dimension III focus on?

Dimension III focuses on United States, and is headquartered in United States.

What is Dimension III's typical check size?

Dimension III typically writes checks of $1M to $30M.